The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, ...

Neumora Therapeutics Inc. (NASDAQ:NMRA) is one of the best IPO stocks to buy according to Wall Street analysts. Earlier on ...

One Simple Walking Adjustment Could Ease Chronic Knee Pain Without Medication, Study Finds originally appeared on Men's ...

In any healthcare setting, 30-40 per cent of patients are there because of pain. Pain may be the main complaint or may be associated with some other ailment. Pain is a protective mechanism of the body ...

Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the ...

While Lagree and pilates do have some similar elements, the two methods are actually quite different. Pilates emphasizes a ...

Lagree and pilates are both reformer-based workouts that can build strength and muscle. Here's which one is better for ...

Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

SaveHealth reports arthritis affects millions, involving joint inflammation and pain. Various types exist, with treatment ...

本研究针对炎症性肠病 (IBD)生物制剂临床应用的安全性与疗效问题，由意大利卡拉布里亚地区团队开展为期一年的多中心药物警戒观察。通过监测214例接受vedolizumab (VDZ)、ustekinumab (UST)等生物制剂治疗的IBD患者，发现44.8%患者出现非严重不良反应 (AEs)，以胃肠道症状 (25%)和皮肤反应 (16.7%)为主，未报告严重不良事件 ...